LAPAHOPE 250MG
DESCRIPTION
Lapahope 250mg belongs to class of antineoplastic drugs which prevents the development and spreading of cancer cells all over the body.
Lapahope 250mg tablet is indicated for metastatic breast Lapahope 250mg tablet cancer and spreading after using of other chemotherapy drugs
 |
| Lapahope 250mg |
INDICATION
Lapahope 250mg with combination of capecitabine is indicated for the treatment of advanced breast cancer after the failure of other cancer medicine.Lapahope 250mg tablet is also combined withLapahope 250mg letrozole is indicated for the treatment postmenopausal women with hormone receptor positive metastatic breast cancer.
MECHANISM OF ACTION
Lapahope 250mg is a type of classification called kinase inhibitor and act by intracellular tyrosine kinase. Lapahope prohibits ErbB-forced tumor cell growth in vitro and in various animal models. When combination 5-fluracil with Lapahope 250mg created an additive effect in the 4 tumor cell lines tested. Development inhibits the Lapahope 250mg tablet effect was examined in trastuzumab-conditioned cell lines.Lapahope 250mg provide selective action against Lapahope 250mg breast cancer cell lines selected for long-term growth in trastuzumab-containing intracellularly. Hormone receptor-positive breast cancer cells (with ER [Estrogen Receptor] and/or Lapahope 250mg tablet PgR [Progesterone Receptor]) that co-express the HER2 bear to be protection against established endocrine therapies. Synchronously Lapahope 250mg hormone receptor-positive breast cancer cellsLapahope 250mg tablet that initially lacks EGFR or HER2 unrecalled these receptor proteins as the tumor becomes resistant to endocrine therapy.
PRODUCT DETAILS
Brand : LapahopeIngredients : Lapatinib
Strength : 250 mg
Manufactured : Glenmark Pharma
Package : 30 Tablets
DOSAGE MANAGEMENT
The usual dose of Lapahope 250mg for adult suffering HER2 positive metastatic breast cancer (with Xeloda) is 1250mg once daily for 1-21days continuously repeating.Femora Combination with Lapahope 250mg tablet the dose recommended is 1500mg orally once a day continuously once daily every day.
Take the drug Lapahope 250mg tablet on an empty stomach (1hr before or 1hr after).
OVERDOSE:
If overdose occurs, seek to emergency Lapahope 250mg department or call poison control helplinePRECAUSION
If you are allergic toLapahope 250mg tablet lapatinib, then do not use the drugIf you had hepatic problem, cardio disease, an electrolytic imbalance then discusses with doctor whether it’s safe to use or not prior toLapahope 250mg tablet Lapahope treatment.
While patients during pregnancy, it should strictly avoid the drug because it harms the unborn baby or cause birth defects.
There is not Lapahope 250mg known whether Lapatinib passes into breast milk.Lapahope 250mg tablet Hence avoid breastfeeding to the infants during Lapahope 250mg tablet treatment
SIDE EFFECT
Lapahope 250mg tablet will cause mild to moderate side effects in patients. If symptoms cause serious the inform the doctor as soon Lapahope 250mg tablet as possible.Common side effect of Lapahope 250mg tablets :
LumbarLapahope 250mg pain; diarrhae; dry skin; nail of finger toe changes; headache; indigestion problem; decreased appetite; mild hair loss orLapahope 250mg tablet thinning; mouth ulcers; nausea; nosebleed; redness and hands and feet will have tingling; weakness; insomnia; vomiting.Serious side effect of Lapahope 250mg tablets :
Severe Lapahope 250mgtightness; difficulty in breathing; unusual bruising or bleeding; unusual itching; yellowing of the eyes or skin; Chest pain; urine will Lapahope 250mg tablet be dark; dizziness or light-headedness; Rapid or irregular heartbeat; pale stools; persistent loss of appetite; severe or persistent cough; severe or Lapahope 250mg tablet persistent diarrhea, nausea, vomiting and skin allergy like itching, rashes, blisters in mouth, face, lip or tongue.EMAIL :millionhealthpharmaceuticals@gmail.com
PHONE NO : +91-9940472902
WEBSITE : https://millionpharma.com/lapahope.php
No comments:
Post a Comment